source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Avacta agrees Affimer reagent licensing deal with New England Biolabs

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, has agreed a commercial licence with Ipswich, Massachusetts, USA based New England Biolabs (NEB), a company specialising in the discovery and production of enzymes for molecular biology applications, to commercialise…

Evonetix partners with LioniX International to enable DNA synthesis at scale

Evonetix, a Cambridge, UK-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, and LioniX International, a global provider of customised microsystem solutions in scalable production volumes, will collaborate to scale up production of prototype microelectromechanical systems (MEMs)…

Owlstone Medical completes $50 million financing

Diagnostics company Owlstone Medical Ltd, which is developing a breathalyser for applications in early disease detection and precision medicine, has completed its financing round to drive the global commercialisation of its Breath Biopsy platform. The round raised a total of…

Zelluna Immunotherapy appoints Dr Namir Hassan as CSO

Zelluna Immunotherapy, a biotechnology company specialising in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, has appointed Dr Namir Hassan as its chief scientific officer (CSO). Dr Hassan has extensive scientific…

Sphere Fluidics appoints Dr Tris Vaughan as scientific advisor

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has appointed Tris Vaughan, PhD, FRSB to its scientific advisory board. The company said that Dr Vaughan’s appointment would further strengthen its understanding of biopharmaceutical…
Subscribe to this RSS feed